Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 7, 2012-04 ,pp. : 672-693

Bentham Science Publishers

Access to resources Recommend Favorite

Slow-Onset Inhibition of 2-trans-Enoyl-ACP (CoA) Reductase from Mycobacterium tuberculosis by an Inorganic Complex

By  

Current Pharmaceutical Design, Vol. 12, Iss. 19, 2006-07 ,pp. : 2409-2424

Bentham Science Publishers

Access to resources Recommend Favorite

Progress on the Discovery of Inhibitors of InhA, the FAS II Enoyl-ACP Reductase TB Drug Discovery Targeted on InhA

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 6, 2016-06 ,pp. : 539-546

Bentham Science Publishers

Access to resources Recommend Favorite

The Mode of Inhibition of Mycobacterium tuberculosis Wild-Type and Isoniazid-Resistant 2-Trans-Enoyl-ACP(CoA) Reductase Enzymes by An Inorganic Complex

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 1, 2008-01 ,pp. : 50-62

Bentham Science Publishers

Access to resources Recommend Favorite

Shikimate Kinase: A Potential Target for Development of Novel Antitubercular Agents

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-03 ,pp. : 459-468

Bentham Science Publishers

Access to resources Recommend Favorite